Cargando…
Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms
The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2, is affecting every aspect of global society, including public healthcare systems, medical care access, and the economy. Although the respiratory tract is primarily affected...
Autores principales: | Villa, Chiara, Rivellini, Eleonora, Lavitrano, Marialuisa, Combi, Romina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780286/ https://www.ncbi.nlm.nih.gov/pubmed/35055344 http://dx.doi.org/10.3390/jpm12010029 |
Ejemplares similares
-
Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
por: Villa, Chiara, et al.
Publicado: (2020) -
Exome Sequencing in an ADSHE Family: VUS Identification and Limits
por: Villa, Chiara, et al.
Publicado: (2022) -
Long Non-Coding RNAs and Related Molecular Pathways in the Pathogenesis of Epilepsy
por: Villa, Chiara, et al.
Publicado: (2019) -
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges
por: Villa, Chiara, et al.
Publicado: (2021) -
Potassium Channels and Human Epileptic Phenotypes: An Updated Overview
por: Villa, Chiara, et al.
Publicado: (2016)